Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15
Published October 17, 2018 · Recall initiated: October 3, 2018
Summary
FDA records drug Class III recall D-0012-2019, published October 17, 2018 and initiated October 3, 2018. Recalling firm: InvaGen Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 2880 bottles; Lot: Lot #: GG80218, Exp. 12/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
What to do
Voluntary: Firm initiated · Letter
Get an email if AMLODIPINE BESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMLODIPINE BESYLATE
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- Distributor
- Nationwide with the United States
- UPC
- 0369097126056
- Lot
- Lot #: GG80218, Exp. 12/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAmlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals,July 19, 2023
- FDAPantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: JubilantOctober 17, 2018
- FDATHYROID POWDER USP, Full Strength (Levothyroxine labeled range of 103-125mcg/grain; Liothyroine (correctOctober 17, 2018
- FDAGlipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: GreenstoneOctober 17, 2018
- FDAAMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd.,September 20, 2017
- FDAAmlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila HealthcareDecember 3, 2014
Questions about this recall
Was Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15 recalled?
Yes. FDA published recall D-0012-2019 on October 17, 2018. Reported hazard: Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMLODIPINE BESYLATE. UPC: 0369097126056.